Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells
Shannon M. White, Maria Laura Avantaggiati, Ivan Nemazanyy, et al.
Developmental Cell (2019) Vol. 49, Iss. 3, pp. 425-443.e9
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs
Lele Zhang, Chaofeng Hou, Chen Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 235
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BioEssays (2020) Vol. 42, Iss. 5
Open Access | Times Cited: 216
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Xiaobo Wang, Bishuang Cai, Xiaoming Yang, et al.
Cell Metabolism (2020) Vol. 31, Iss. 5, pp. 969-986.e7
Open Access | Times Cited: 159
YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
Frank Szulzewsky, Eric C. Holland, Valeri Vasioukhin
Developmental Biology (2021) Vol. 475, pp. 205-221
Open Access | Times Cited: 111
BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency
Feixia Wang, Yifeng Liu, Fei-Da Ni, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 74
Extracellular matrix stiffness as an energy metabolism regulator drives osteogenic differentiation in mesenchymal stem cells
Jing Na, Zhijie Yang, Qiusheng Shi, et al.
Bioactive Materials (2024) Vol. 35, pp. 549-563
Open Access | Times Cited: 20
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Chad Stroope, Felix Sebastian Nettersheim, Brian G. Coon, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 617-638
Open Access | Times Cited: 18
Integration of Hippo-YAP Signaling with Metabolism
Consuelo Ibar, Kenneth D. Irvine
Developmental Cell (2020) Vol. 54, Iss. 2, pp. 256-267
Open Access | Times Cited: 113
A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
Hirohito Yamaguchi, Ghina M. Taouk
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 82
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Jack P. Gleeson, Ines Nikolovski, Renzo G. DiNatale, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 10, pp. 2910-2919
Open Access | Times Cited: 62
Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma
Yongyun Li, Jie Yang, Qianqian Zhang, et al.
Oncogene (2022) Vol. 41, Iss. 27, pp. 3539-3553
Open Access | Times Cited: 44
New insights into the ambivalent role of YAP/TAZ in human cancers
Juan Luo, Liang Deng, Hailin Zou, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 30
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
A. Cole Edwards, Clint A. Stalnecker, Alexis Jean Morales, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4112-4129
Open Access | Times Cited: 30
Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers
Hongge Liang, Yan Xu, Jing Zhao, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 652-666
Open Access | Times Cited: 13
A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas
Shigekazu Murakami, Ivan Nemazanyy, Shannon M. White, et al.
Developmental Cell (2019) Vol. 51, Iss. 1, pp. 113-128.e9
Open Access | Times Cited: 60
The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
Ping‐Chih Hsu, Cheng‐Ta Yang, David M. Jablons, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1361-1361
Open Access | Times Cited: 59
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance
Ankur Chakravarthy, Ian Reddin, Stephen Henderson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 20
YAP/TAZ: Molecular pathway and disease therapy
Yuzi Wei, Victoria Lee Zhi Hui, Yilin Chen, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 19
Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 17
Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis
Ahmed Raslan, Tho X. Pham, Jisu Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
The molecular biology of NF2/Merlin on tumorigenesis and development
Rexhina Vlashi, Fuju Sun, Chenggong Zheng, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Closed Access | Times Cited: 6
Regulation of cancer progression by circRNA and functional proteins
Junhong Chen, Jie Gu, Mengtian Tang, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 373-388
Closed Access | Times Cited: 38
Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review
Hiroshi Kobayashi
Heliyon (2022) Vol. 8, Iss. 11, pp. e11487-e11487
Open Access | Times Cited: 27
Genome-wide and targeted CRISPR screens identify RNF213 as a mediator of interferon gamma–dependent pathogen restriction in human cells
Sumit K. Matta, Hinissan P. Kohio, Pallavi Chandra, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 121, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top